Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Debt Ratio (2016 - 2025)

IGC Pharma has reported Debt Ratio over the past 15 years, most recently at 0.01 for Q3 2025.

  • Quarterly Debt Ratio rose 4.06% to 0.01 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.01 through Sep 2025, up 4.06% year-over-year, with the annual reading at 0.02 for FY2025, 10.73% up from the prior year.
  • Debt Ratio was 0.01 for Q3 2025 at IGC Pharma, down from 0.02 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.02 in Q2 2025 and troughed at 0.0 in Q2 2021.
  • The 5-year median for Debt Ratio is 0.01 (2023), against an average of 0.01.
  • The largest YoY upside for Debt Ratio was 837.39% in 2021 against a maximum downside of 80.44% in 2021.
  • A 5-year view of Debt Ratio shows it stood at 0.0 in 2021, then soared by 48.52% to 0.01 in 2022, then skyrocketed by 74.46% to 0.01 in 2023, then grew by 20.43% to 0.01 in 2024, then decreased by 8.22% to 0.01 in 2025.
  • Per Business Quant, the three most recent readings for IGC's Debt Ratio are 0.01 (Q3 2025), 0.02 (Q2 2025), and 0.02 (Q1 2025).